Boosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticles

dc.contributor.authorMora, Blanca de Juan
dc.contributor.authorFilipe, Luís
dc.contributor.authorForte, Andreia
dc.contributor.authorSantos, Miguel M.
dc.contributor.authorAlves, Celso
dc.contributor.authorTeodoro, Fernando
dc.contributor.authorPedrosa, Rui
dc.contributor.authorRibeiro Carrott, Manuela
dc.contributor.authorBranco, Luís C.
dc.contributor.authorGago, Sandra
dc.contributor.editorPrestidge, Clive
dc.contributor.editorDosio, Franco
dc.date.accessioned2021-02-17T11:15:51Z
dc.date.available2021-02-17T11:15:51Z
dc.date.issued2021-02-05
dc.description.abstractMesoporous silica nanoparticles (MSNs) are very promising nanomaterials for treating bacterial infections when combined with pharmaceutical drugs. Herein, we report the preparation of two nanomaterials based on the immobilization of ciprofloxacin in mesoporous silica nanoparticles,either as the counter-ion of the choline derivative cation MSN-[Ch][Cip]) or via anchoring on the surface of amino-group modified MSNs via an amide bond (MSN-Cip). Both nanomaterials were characterized by TEM, FTIR and solution 1H NMR spectroscopies, elemental analysis, XRD and N2 adsorption at 77 K in order to provide the desired structures. No cytotoxicity from the prepared mesoporous nanoparticles on 3T3 murine fibroblasts was observed. The antimicrobial activity of the nanomaterials was determined against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Klebsiella pneumoniae) bacteria and the results were promising against S. aureus. In the case of B. subtilis, both nanomaterials exhibited higher antimicrobial activity than the precursor [Ch][Cip], and in the case of K. pneumoniae they exhibited higher activity than neutral ciprofloxacin.por
dc.description.sponsorshipFCTpor
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.authoremailnd
dc.identifier.citationde Juan Mora, B.; Filipe, L.; Forte, A.; Santos, M.M.; Alves, C.; Teodoro, F.; Pedrosa, R.; Ribeiro Carrott, M.; Branco, L.C.; Gago, S. Boosting Antimicrobial Activity of Ciprofloxacin by Functionalization of Mesoporous Silica Nanoparticles. Pharmaceutics 2021, 13, 218.por
dc.identifier.doidoi.org/10.3390/pharmaceutics13020218por
dc.identifier.revistaPharmaceutics
dc.identifier.scientificarea306por
dc.identifier.sharewithLAQV-REQUIMTE; QUIpor
dc.identifier.urihttps://doi.org/10.3390/pharmaceutics13020218
dc.identifier.urihttp://hdl.handle.net/10174/29114
dc.identifier.volume13
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherMDPIpor
dc.rightsopenAccesspor
dc.subjectMesoporous Silica Nanoparticlespor
dc.subjectIonic Liquidspor
dc.subjectCiprofloxacinpor
dc.subjectCytotoxicitypor
dc.subjectAntimicrobial activitypor
dc.titleBoosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticlespor
dc.typearticlepor

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pharmaceutics-13-00218-v2.pdf
Size:
2.63 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
3.89 KB
Format:
Item-specific license agreed upon to submission
Description: